Loading...
Docoh

Clearside Biomedical (CLSD)

News

From Benzinga Pro
Clearside Biomedical: Q1 Earnings Insights
11 May 22
Earnings
Clearside Biomedical (NASDAQ:CLSD) reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Clearside Biomedical Q1 EPS $(0.13) Misses $(0.08) Estimate
11 May 22
Earnings, News
Clearside Biomedical (NASDAQ:CLSD) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.08) by 62.5 percent. This is unchanged from the same period last year.
Earnings Scheduled For May 11, 2022
11 May 22
Earnings, News, Pre-Market Outlook, Markets
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Clearside Biomedical Says Poster Presentation At ARVO 2022 Annual Meeting Demonstrates Versatility Of Suprachoroidal Delivery Technology
5 May 22
News, FDA, Events
Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology - Multiple Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing
20 Stocks Moving in Wednesday's Pre-Market Session
27 Apr 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) shares rose 100.9% to $2.13 in pre-market trading after jumping over 16% on Tuesday. Cosmos Holdings recently posted FY21 adjusted net income of $384K.
Bausch + Lomb And Clearside Biomedical Announce The U.S. Commercial Launch Of XIPERE For Suprachoroidal Use For The Treatment Of Macular Edema Associated With Uveitis
28 Mar 22
News
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (TSX:BHC) ("Bausch Health"), and Clearside Biomedical, Inc. (NASDAQ:CLSD) ("Clearside"), a biopharmaceutical company
30 Stocks Moving in Tuesday's Pre-Market Session
22 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Smart for Life, Inc. (NASDAQ: SMFL) rose 75.3% to $1.63 in pre-market trading. Smart For Life recently said it is launching various products under the Doctors Scientific Organica brand on Amazon Singapore.
68 Biggest Movers From Yesterday
16 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Sonim Technologies, Inc. (NASDAQ: SONM) shares jumped 103.3% to settle at $1.22 on Tuesday after the company announced its XP8 smartphone has integrated with the Walkie Talkie in Microsoft Teams.
38 Stocks Moving In Tuesday's Mid-Day Session
15 Mar 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers
12 Health Care Stocks Moving In Monday's Pre-Market Session
14 Mar 22
Pre-Market Outlook, Markets, Movers
95 Biggest Movers From Friday
14 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Gainers Marygold Companies (NYSE: MGLD) shares surged 89.4% to close at $4.11 on Friday after dropping 21% on Thursday. TeraWulf Inc. (NASDAQ: WULF) gained 49.3% to close at $9.51.
Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Orphazyme Shares Plunge
11 Mar 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq dropping 150 points on Friday.
12 Health Care Stocks Moving In Friday's Intraday Session
11 Mar 22
Intraday Update, Markets, Movers
Mid-Day Market Update: Gold Down 1%; Clearside Biomedical Shares Jump
11 Mar 22
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets
U.S. stocks traded mixed midway through trading, with the Nasdaq dropping around 100 points on Friday.
50 Stocks Moving In Friday's Mid-Day Session
11 Mar 22
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
Gainers Marygold Companies (NYSE: MGLD) jumped 189.4% to $6.28 after dropping 21% on Thursday.
Why Clearside Biomedical Shares Are Surging Today
11 Mar 22
Earnings, News, Penny Stocks, Movers, Trading Ideas
Clearside Biomedical Inc (NASDAQ: CLSD) shares are trading higher Friday after the company reported better-than-expected fourth-quarter financial results.
JMP Securities Maintains Market Outperform on Clearside Biomedical, Lowers Price Target to $10
11 Mar 22
News, Price Target, Analyst Ratings
JMP Securities analyst Jonathan Wolleben maintains Clearside Biomedical (NASDAQ:CLSD) with a Market Outperform and lowers the price target from $11 to $10.
The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China
11 Mar 22
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours.
30 Stocks Moving in Friday's Pre-Market Session
11 Mar 22
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Benzinga's After-Hours Movers & News: DocuSign, Clearside Biomedical And More
10 Mar 22
News, Penny Stocks, Small Cap, After-Hours Center, Trading Ideas
Benzinga's “After-Hours Movers & News” highlights the biggest movers of the day. The information on the price action is collected using Benzinga Pro's Movers tool. Benzinga Pro users can cross-reference the Movers tool with the Benzinga Pro News tool to identify potential news catalysts moving stocks.

Press releases

From Benzinga Pro
Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update
11 May 22
Earnings, Press Releases
- First Approved Suprachoroidal Product, XIPERE®, Now Commercially Available in U.S. - - Cohort 4 Enrolling at 1.0 mg Dose in CLS-AX OASIS Wet AMD Phase 1/2a Trial - - Management to Host Webcast and Conference
Clearside Biomedical Poster Presentation at ARVO 2022 Annual Meeting Demonstrates Versatility of Suprachoroidal Delivery Technology
5 May 22
Health Care, Press Releases
- Multiple Poster Presentations on XIPERE® and Gene Therapy Delivery Utilizing SCS Microinjector® - - Dr. Thomas Ciulla to Participate in a Panel Discussion at Retina World Congress 2022 on May 12, 2022 -
Clearside Biomedical to Report First Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, May 11, 2022
29 Apr 22
News, Press Releases
ALPHARETTA, Ga., April 29, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal
Clearside Biomedical to Present at the Needham Virtual Healthcare Conference
6 Apr 22
Press Releases
ALPHARETTA, Ga., April 06, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal
Thinking about buying stock in ORIC Pharmaceuticals, WiMi Hologram Cloud, Clearside Biomedical, Stronghold Digital Mining, or GasLog Partners?
28 Mar 22
Opinion, Press Releases
NEW YORK, March 28, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ORIC, WIMI, CLSD, SDIG, and GLOP.
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis
28 Mar 22
Press Releases
XIPERE® is the First and Only FDA-Approved Therapy for Delivery via Suprachoroidal Injection LAVAL, QC and ALPHARETTA, Ga., March 28, 2022 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of
Thinking about buying stock in Clearside Biomedical, Pearson, Paramount Gold Nevada, Hycroft Mining, or Alto Ingredients?
11 Mar 22
Opinion, Press Releases
NEW YORK, March 11, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CLSD, PSO, PZG, HYMC, and ALTO.
Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors
3 Mar 22
News, Management, Press Releases
ALPHARETTA, Ga., March 03, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal
Clearside Biomedical to Participate in Two Upcoming Investor Conferences in March 2022
1 Mar 22
News, Press Releases
ALPHARETTA, Ga., March 01, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal
Clearside Biomedical to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update on Thursday, March 10, 2022
25 Feb 22
News, Press Releases
ALPHARETTA, Ga., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space